Benefit of statins greater than previously thought

Statins are cost-effective and should be used in a wider group of people than recommended in current guidelines, according to a study published in the BMJ.

Simvastatin
Simvastatin
The researchers have shown that generic simvastatin treatment was cost-effective in people as young as 35 and as old as 85 with an annual risk of major vascular event as low as 1 per cent, a threshold well below current NICE guidance.

Heart Protection Study

This new research used data from the Heart Protection Study (HPS) is a landmark trial of simvastatin undertaken in 2005.

The HPS showed that when cheaper generic versions of statins are used, several years of treatment is cost-effective for a wide range of people with vascular disease or diabetes.

The HPS involved over 20,000 individuals with heart disease or diabetes. They were given either 40mg of simvastatin daily or placebo for five years.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...

Vaccines

Monkeypox jabs will run out by next week, UKHSA says

The UK is likely to run out of smallpox vaccine stocks which it is using to protect...

NHS sign outside a building

Two Midlands hospitals end partnerships with Babylon

Two NHS trusts have prematurely severed their relationships with digital health provider,...